Cutaneous sporotrichosis treatment with potassium iodide. A 24 year experience in São Paulo state, Brazil;Tratamento da esporotricose cutânea com SSKI. Experiência de 24 anos no estado de São Paulo, Brasil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 53, Issue 2, 2011, Pages 89-93

  Yamada, Karin ^a   Zaitz, Clarisse ^a   Framil, Valéria Maria de Souza ^a   Muramatu, Laura Hitomi ^b  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b ICBIIUSP   (Brazil)

Author keywords

Mycosis; Potassium iodide; Sporothrix schenckii; Sporotrichosis

Indexed keywords

POTASSIUM IODIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CUTANEOUS SPOROTRICHOSIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; LYMPHOCUTANEOUS SPOROTRICHOSIS; MALE; MEDICAL RECORD REVIEW; NAUSEA; PRESCHOOL CHILD; REINFECTION; RELAPSE; SEX DIFFERENCE; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; TREATMENT DURATION;

EID: 79955887229     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652011000200006     Document Type: Article

References (28)

1. Barros MBL, Schubach TMP, Gutierrez Galhardo MC, Schubach AO, Monteiro PCF, Reis RS, et al. Sporotrichosis: an emergent zoonosis in Rio de Janeiro. Mem Inst Oswaldo Cruz. 2001;96:777-9.
2. Campbell I. Esporotricose. In: Zaitz C, Campbell I, Marques SA, Ruiz LRB, Souza VM. Compêndio de micologia médica. Rio de Janeiro: MEDSI; 1998. p. 123-137.
3. -1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Mycoses. 2004;47(1-2): 62-8.
4. Conias S, Wilson P. Epidemic cutaneous sporotrichosis: report of 16 cases in Queensland due to mouldy hay. Australas J Dermatol. 1998;39:34-7.
5. Da Rosa ACM, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52(3 Pt 1):451-9.
6. De Araujo T, Marques AC, Kerdel F. Sporotrichosis. Int J Dermatol. 2001;40:737-42.
7. Donadel KW, Reinoso YD, de Oliveira JC, Azulay RD. Esporotricose: revisão. An Bras Dermatol. 1993;68:45-52.
8. Gurcan S, Konuk E, Kilic H, Otkun M, Ener B. Sporotrichosis, a disease rarely reported from Turkey, and an overview of Turkish literature. Mycoses. 2007;50:426-9.
9. Habte-Gabr E, Walsh W. Cutaneous sporotrichosis: the old iodide treatment remains effective. Clin Microbiol Infect. 2000;6:55.
10. Heymann WR. Potassium iodide and the Wolff-Chaikoff effect: relevance for the dermatologist. J Am Acad Dermatol. 2000;42:490-2.
11. Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255-65.
12. Koç AN, Uksal U, Oymak O. Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey. Mycoses. 2001;44:330-3.
13. aed. São Paulo: Sarvier; 2002. p. 479-497.
14. Londero AT, Ramos CD. Esporotricose no Rio Grande do Sul: três decadas de observação. An Bras Dermatol. 1989;64:307-10.
15. Lopes JO, Alves SH, Mari CR, Brum LM, Westphalen JB, Altermann MJ, et al. Epidemiologia da esporotricose na regiäo central do Rio Grande do Sul. Rev Soc Bras Med Trop. 1999;32:541-5.
16. Lopes-Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc. 2006;78:293-308.
17. Lorenz AM, de los Ríos E, de los Ríos R, Cartagena N. Esporotricosis linfangítica. Dermatol. Argent. 2003;9:192-3.
18. Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME, et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis. 2003;36:34-9.
19. Marques SA, Sueto M, Camargo RMP, Lastória JC, Fagundes LK, Dillon NL. Sporotrichosis: survey and clinical aspects from Botucatu School of Medicine, state of Säo Paulo-Brazil. An Bras Dermatol. 1997;72:343-7.
20. Marques SA, Franco SRVS, Camargo RMP, Dias LDF, Haddad Júnior V, Fabris VE. Esporotricose do gato doméstico (Felis catus): transmissão humana. Rev Inst Med Trop Sao Paulo. 1993;35:327-30.
21. Mohan N, Jayaseelan E, Abraham A, Rajendran SC, Stephen J, Sharief S, et al. Cutaneous sporotrichosis in Bangalore, southern India. Int J Dermatol. 2004;43:269-72.
22. Morris-Jones R. Sporotrichosis. Clin Exp Dermatol. 2002;27:427-31.
23. Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000;30:65-70.
24. Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25:181-7.
25. Schubach A, Barros MBL, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis. 2008;21:129-33.
26. st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol. 2000;43:691-7.
27. Tanuma H, Asai T, Abe M, Nishiyama S, Katsuoka K. Case report. Lymphatic vessel-type sporotrichosis: immunohistochemical evaluation and cytokine expression pattern. Mycoses. 2001;44:316-20.
28. Zaitz C, Ruiz LRB, de Souza VM. Identificação dos fungos. In: Zaitz C, Ruiz LRB, de Souza VM. Atlas de micologia. Rio de Janeiro: MEDSI; 2004. p. 29.